These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28720327)

  • 1. Asymmetric synthesis and evaluation of epoxy-α-acyloxycarboxamides as selective inhibitors of cathepsin L.
    Dos Santos DA; Deobald AM; Cornelio VE; Ávila RMD; Cornea RC; Bernasconi GCR; Paixão MW; Vieira PC; Corrêa AG
    Bioorg Med Chem; 2017 Sep; 25(17):4620-4627. PubMed ID: 28720327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of new peptide amides as selective cathepsin L inhibitors: the first step towards selective irreversible inhibitors?
    Torkar A; Lenarčič B; Lah T; Dive V; Devel L
    Bioorg Med Chem Lett; 2013 May; 23(10):2968-73. PubMed ID: 23562595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.
    Alper PB; Liu H; Chatterjee AK; Nguyen KT; Tully DC; Tumanut C; Li J; Harris JL; Tuntland T; Chang J; Gordon P; Hollenbeck T; Karanewsky DS
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1486-90. PubMed ID: 16412634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituents.
    Altmann E; Green J; Tintelnot-Blomley M
    Bioorg Med Chem Lett; 2003 Jun; 13(12):1997-2001. PubMed ID: 12781182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
    Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors.
    Kishore Kumar GD; Chavarria GE; Charlton-Sevcik AK; Arispe WM; Macdonough MT; Strecker TE; Chen SE; Siim BG; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1415-9. PubMed ID: 20089402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green asymmetric synthesis of epoxypeptidomimetics and evaluation as human cathepsin K inhibitors.
    Silva TL; Dos Santos DA; de Jesus HCR; Brömme D; Fernandes JB; Paixão MW; Corrêa AG; Vieira PC
    Bioorg Med Chem; 2020 Aug; 28(15):115597. PubMed ID: 32631567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of papain-family cathepsin L-like cysteine protease inhibitors containing a 1,4-benzodiazepine scaffold as antiprotozoal agents.
    Ettari R; Pinto A; Tamborini L; Angelo IC; Grasso S; Zappalà M; Capodicasa N; Yzeiraj L; Gruber E; Aminake MN; Pradel G; Schirmeister T; De Micheli C; Conti P
    ChemMedChem; 2014 Aug; 9(8):1817-25. PubMed ID: 24919925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a highly potent, selective, and cell-active inhibitor of cysteine cathepsin L-A hybrid design approach.
    Dana D; De S; Rathod P; Davalos AR; Novoa DA; Paroly S; Torres VM; Afzal N; Lankalapalli RS; Rotenberg SA; Chang EJ; Subramaniam G; Kumar S
    Chem Commun (Camb); 2014 Sep; 50(74):10875-8. PubMed ID: 25089379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel and selective cathepsin L inhibitor with anti-metastatic ability in vitro and in vivo against breast cancer cells.
    Li Y; Ai X; Zou C; Liu Y; Ma L; Men J; Liu D; Sheng L; Ruan X; Liu H; Li W; Ma E; Yuan L
    Bioorg Chem; 2021 Oct; 115():105256. PubMed ID: 34426153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New aziridine-based inhibitors of cathepsin L-like cysteine proteases with selectivity for the Leishmania cysteine protease LmCPB2.8.
    Fey P; Chartomatsidou R; Kiefer W; Mottram JC; Kersten C; Schirmeister T
    Eur J Med Chem; 2018 Aug; 156():587-597. PubMed ID: 30029081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalized benzophenone, thiophene, pyridine, and fluorene thiosemicarbazone derivatives as inhibitors of cathepsin L.
    Kumar GD; Chavarria GE; Charlton-Sevcik AK; Yoo GK; Song J; Strecker TE; Siim BG; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6610-5. PubMed ID: 20933415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
    Schirmeister T
    J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments.
    Chowdhury SR; Kennedy S; Zhu K; Mishra R; Chuong P; Nguyen AU; Kathman SG; Statsyuk AV
    Bioorg Med Chem Lett; 2019 Jan; 29(1):36-39. PubMed ID: 30455147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.
    Tavares FX; Boncek V; Deaton DN; Hassell AM; Long ST; Miller AB; Payne AA; Miller LR; Shewchuk LM; Wells-Knecht K; Willard DH; Wright LL; Zhou HQ
    J Med Chem; 2004 Jan; 47(3):588-99. PubMed ID: 14736240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of rhodesain inhibitors with a 3-bromoisoxazoline warhead.
    Ettari R; Tamborini L; Angelo IC; Grasso S; Schirmeister T; Lo Presti L; De Micheli C; Pinto A; Conti P
    ChemMedChem; 2013 Dec; 8(12):2070-6. PubMed ID: 24243827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorine Scan of Inhibitors of the Cysteine Protease Human Cathepsin L: Dipolar and Quadrupolar Effects in the π-Stacking of Fluorinated Phenyl Rings on Peptide Amide Bonds.
    Giroud M; Harder M; Kuhn B; Haap W; Trapp N; Schweizer WB; Schirmeister T; Diederich F
    ChemMedChem; 2016 May; 11(10):1042-7. PubMed ID: 27095165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary amides as selective inhibitors of cathepsin K.
    Léger S; Bayly CI; Black WC; Desmarais S; Falgueyret JP; Massé F; Percival MD; Truchon JF
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4328-32. PubMed ID: 17544269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.
    Barrett DG; Catalano JG; Deaton DN; Hassell AM; Long ST; Miller AB; Miller LR; Ray JA; Samano V; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1735-9. PubMed ID: 16376075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptide-derived nitriles containing additional electrophilic sites: potentially irreversible inhibitors of cysteine proteases.
    Löser R; Gütschow M
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1245-52. PubMed ID: 19912058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.